← Back to Screener
Canton Strategic Holdings, Inc. Common Stock (CNTN)
Price$2.81
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)21.85%
Price vs S&P 500 (4W)-9.00%
VGM Score44.12
Market Capitalization$216.40M
All Metrics
Book Value / Share (Quarterly)$8.29
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-2.71
Price vs S&P 500 (YTD)-8.62%
EPS (TTM)$-2.13
10-Day Avg Trading Volume0.51M
EPS Excl Extra (TTM)$-2.13
EPS (Annual)$-1.12
ROI (Annual)-9.03%
Cash / Share (Quarterly)$0.73
ROA (Last FY)-6.92%
EBITD / Share (TTM)$-1.47
Cash Flow / Share (Annual)$-2.52
P/B Ratio0.46x
P/B Ratio (Quarterly)0.39x
Net Income / Employee (Annual)$-2,993,000
Net Interest Coverage (TTM)-4.33x
ROA (TTM)-28.98%
EPS Incl Extra (Annual)$-1.12
Current Ratio (Annual)157.97x
Quick Ratio (Quarterly)510.89x
3-Month Avg Trading Volume0.79M
52-Week Price Return109.46%
Revenue / Employee (TTM)$0
52-Week High$9.08
EPS Excl Extra (Annual)$-1.12
26-Week Price Return37.78%
Quick Ratio (Annual)157.86x
13-Week Price Return-38.25%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)512.25x
Enterprise Value$174.86M
Revenue / Employee (Annual)$0
Cash / Share (Annual)$0.46
3-Month Return Std Dev75.97%
Net Income / Employee (TTM)$-6,726,500
ROE (Last FY)-9.03%
Net Interest Coverage (Annual)-322.02x
EPS Basic Excl Extra (Annual)$-1.12
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-2.13
ROI (TTM)-36.91%
Revenue / Share (Annual)$0.00
Price vs S&P 500 (52W)81.25%
Year-to-Date Return2.31%
5-Day Price Return-11.93%
EPS Normalized (Annual)$-1.12
ROA (5Y Avg)-180.25%
Month-to-Date Return-4.02%
EBITD / Share (Annual)$-1.31
LT Debt / Equity (Annual)0.00x
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-2.13
Price vs S&P 500 (13W)-47.99%
Beta1.47x
Revenue / Share (TTM)$0.00
ROE (TTM)-36.93%
52-Week Low$1.08
mGradeC
vgmGradeC
Show chart for
Analyst Recommendations
Sep 2025
Oct 2025
Nov 2025
Dec 2025
4.14
4.14
4.14
4.14
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
CNTNCanton Strategic Holdings, Inc. Common Stock | — | — | C | $2.81 |
| LLYEli Lilly & Co. | D | B | B | $1082.20 |
| JNJJohnson & Johnson | C | C | C | $223.51 |
| ABBVABBVIE INC. | D | C | C | $212.93 |
| MRKMerck & Co., Inc. | C | C | C | $115.17 |
| NVSNovartis AG | C | C | C | $145.68 |
| AZNAstraZeneca PLC | D | B | C | $179.71 |
| NVONovo-Nordisk A/S | B | B | C | $44.07 |
| PFEPfizer Inc. | B | C | C | $25.63 |
| ABTAbbott Laboratories | C | C | D | $87.78 |
| TEVATeva Pharmaceutical Industries Limited American Depositary Shares | C | C | C | $34.64 |
About
Canton Strategic Holdings Inc operates two distinct business segments: a blockchain infrastructure business centered on the Canton Network, where it runs a validator node and facilitates financial market digitization through Canton Coin, and a clinical-stage biotech company developing therapeutics for neurological and respiratory disorders. The biotech division's lead candidate, GV104, is in clinical development for respiratory and nervous system depression in military personnel and first responders, with plans to expand into additional indications. The pipeline includes GV023 for autoimmune diseases and an early-stage multispecific biologic platform.